phase

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinsons Disease

December 05, 2025 08:00 ET  | Source: Amneal Pharmaceuticals LLC Interim data show substantial improvements in “Good On” time compared…

1 month ago

NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation

SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- NobleAI, the leader in practical AI solutions for chemistry and energy, announced…

1 month ago

Plume Appoints Lorie Boyd as Chief People Officer

Boyd brings deep HR and workforce management experience from Turo and Zendesk to help Plume scale through next phase of…

1 month ago

Yatra Strengthens Leadership for Next Phase of Growth

Elevates Co-Founder Dhruv Shringi to Executive Chairman; Appoints Siddhartha Gupta as CEONEW DELHI, Nov. 25, 2025 /PRNewswire/ -- Yatra Online…

1 month ago

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

1 month ago

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

November 26, 2025 19:00 ET  | Source: HUTCHMED (China) Limited HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27,…

1 month ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

1 month ago

Alzheimer’s Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment PipelineCHICAGO, Nov. 24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed…

1 month ago

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…

2 months ago

GMR001 HYPERCAR TESTING REACHES NEW PHASE WITH FIRST PERFORMANCE AND WET WEATHER RUNNING

Testing of the GMR-001 Hypercar entered a new phase last week at Circuit Magny-Cours in France where Genesis Magma Racing…

2 months ago